Antrogen has newly appeared among the top searched stocks.

As of 9:30 AM on the 22nd, Antrogen is trading at 53,900 KRW, up 0.37% from the previous day. This represents a 59.94% increase compared to May 19. Antrogen is known as a developer and seller of stem cell therapies.

Over the past five days, individual investors have net sold 14,386 shares, while foreign investors and institutions have net sold 2,410 shares and 2,177 shares, respectively.

On May 21, Antrogen became a market issue with the headline "Diabetic Foot Ulcer Treatment Receives FDA Approval, Surges for Second Day."

※Source: AI Investment Assistant AI Rasero

※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and financial AI specialist company Thinkpool.




This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing